Vyvanse 30 MG capsule 100S
Ended Awarded
- Contract number
- SPE2DB25FN3KS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,522
Award facts
- Contract value 100% obligated
- $5,521.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $5,521.78 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 30 mg, a prescription stimulant medication commonly used to treat attention-deficit/hyperactivity disorder and narcolepsy. Issued on July 28, 2025, with an ultimate completion date of July 29, 2025, this firm fixed-price contract represents a competitively awarded, non-set-aside procurement with performance to be executed from the vendor's corporate office in Conshohocken, Pennsylvania. The delivery order constitutes a child contract under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical prime vendor agreement valued through December 2026 that authorizes the company to supply a comprehensive range of pharmaceuticals and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a substantial federal contract portfolio predominantly with the Defense Logistics Agency's Medical Supply Chain, reflecting its critical role in supplying medications and medical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's contract awards historically demonstrate versatility in fulfilling federal medical procurement requirements across diverse therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and specialized medical supplies, with pricing structures typically employing firm fixed-price arrangements across transaction values ranging from under $100 to exceeding $45,000.
Quick answers
Who was awarded contract SPE2DB25FN3KS?
SPE2DB25FN3KS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 28, 2025.
How much is contract SPE2DB25FN3KS worth?
The government has obligated $5,522 on SPE2DB25FN3KS.
Is contract SPE2DB25FN3KS an order under another contract?
Yes. SPE2DB25FN3KS is a delivery order under SPE2DB22D1200, an indefinite delivery contract.
Was contract SPE2DB25FN3KS competed?
The extent of competition for SPE2DB25FN3KS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award